Previous
Previous

Non-criteria antiphospholipid antibodies and calprotectin as potential biomarkers in pediatric antiphospholipid syndrome

Next
Next

Clinical Care of Pediatric Patients with or at-risk of the post-thrombotic syndrome: Guidance from the Pediatric and Neonatal Thrombosis and Haemostasis Subcommittee of the ISTH